Patients with secondary progressive multiple sclerosis (SPMS) are lacking efficient medication
to slow down the progression of their disease. PET imaging holds promise as a method to …

Overactivation of microglia is associated with most neurodegenerative diseases. In this
study we examined whether PET-measurable innate immune cell activation predicts multiple …

Background: Cerebrospinal fluid (CSF) levels of two soluble biomarkers, glial fibrillary acidic
protein (GFAP) and neurofilament light chain (NfL), have been shown to associate with …

In this study, positron emission tomography (PET) imaging with a radioligand to adenosine
A2A receptors (A2AR)—a potent regulator of inflammation—was used to gain insight into the …

Neurofilament light chain (NfL) is a novel biomarker reflecting neuroaxonal damage and
associates with brain atrophy, and glial fibrillary acidic protein (GFAP) is a marker of astrocytic …

Purpose The purpose of this study was to investigate the effects of ageing, sex and body
mass index (BMI) on translocator protein (TSPO) availability in healthy subjects using positron …

Traditionally, multiple sclerosis (MS) has been considered a white matter disease with focal
inflammatory lesions. It is, however, becoming clear that significant pathology, such as …

Understanding the mechanisms underlying progression in multiple sclerosis (MS) is one of
the key elements contributing to the identification of appropriate therapeutic targets for this …

Objective To investigate the relationship of in vivo microglial activation to clinical and MRI
parameters in MS. Methods Patients with secondary progressive MS (n = 10) or relapsing-…

Conventional MR imaging (MRI) techniques form the cornerstone of multiple sclerosis (MS)
diagnostics and clinical follow-up today. MRI is sensitive in demonstrating focal inflammatory …